| View |
|
DR-XY43320
|
Isopropanolol+benzalkonium Chloride
|
Cutasept F
|
63g/0.025g per 100g
|
Solution
|
Disinfectant /Antiseptic
|
Bode Chemie GmbH
|
Germany
|
Renewal
|
09 March 2024
|
19 March 2029
|
| View |
|
DR-XY43321
|
TRIMETAZIDINE HYDROCHLORIDE
|
VASEREL
|
35mg
|
Modified Release Film-Coated Tablet
|
Fatty Acid Oxidation (pFOX) Inhibitor
|
Aurochem Laboratories (India) Pvt. Ltd.
|
India
|
Renewal
|
25 April 2024
|
15 April 2029
|
| View |
|
DR-XY43323
|
Rifampicin (Rifacare) ; Isonizid + Pyridoxine Hydrochloride (Isoprim)
|
Prime Kit Duo
|
200 mg/5 mL ; 200 mg /20 mg per 5 mL
|
Suspension ; Syrup
|
Anti-Tuberculosis
|
J.M Tollman Laboratories, Inc.
|
Philippines
|
Automatic Renewal
|
23 February 2022
|
20 March 2027
|
| View |
|
DR-XY43324
|
Fexofenadine Hydrochloride
|
Nysotab
|
180mg
|
Film-Coated Tablet
|
Antihistamine
|
Aurochem Laboratories
|
India
|
Renewal
|
17 April 2024
|
24 March 2029
|
| View |
|
DR-XY43328
|
Ketoconazole
|
Ketozol
|
20mg/g(2% w/w)
|
Cream
|
Antifungal
|
Bal Pharma Limited
|
India
|
Renewal
|
16 February 2024
|
01 April 2029
|
| View |
|
DR-XY43329
|
Raloxifene Hydrochloride
|
Larfen
|
60 mg
|
Film Coated Tablet
|
Selective Estrogen Receptor Modulator
|
Pharmathen SA
|
Greece
|
Renewal
|
23 November 2023
|
01 April 2029
|
| View |
|
DR-XY43330
|
Cilostazol
|
Clauden
|
50 mg
|
Tablet
|
Antiplatelet (Phosphodiesterase Inhibitor)
|
Lloyd Laboratories, Inc.
|
Philippines
|
Renewal
|
18 December 2023
|
01 April 2029
|
| View |
|
DR-XY43331
|
Levocetirizine Hydrochloride
|
Levocer
|
5mg
|
Film-Coated Tablet
|
Antihistamine
|
Aurochem Laboratories
|
India
|
Renewal
|
02 April 2024
|
01 April 2029
|
| View |
|
DR-XY43332
|
Sodium Chloride
|
Unbranded
|
0.90%
|
Intravenous Injection
|
Diluent
|
Otsuka Pharmaceutical India Private Limited
|
India
|
Renewal
|
16 April 2024
|
01 April 2029
|
| View |
|
DR-XY43337
|
Sodium Alginate + Sodium Bicarbonate + Calcium Carbonate
|
Gaviscon Double Action
|
500mg / 213 mg / 325mg per 10mL
|
Suspension
|
Antacid
|
Reckitt Benckiser Healthcare (UK) Limited
|
United Kingdom
|
Renewal
|
27 October 2023
|
03 April 2029
|
| View |
|
DR-XY43338
|
Olopatadine Solution (Eye Drops) as hydrochloride
|
Patadin
|
1mg/Ml (0.1% w/v)
|
Ophthalmic Solution (Eye Drops)
|
Anti histamine
|
Popular Pharmaceuticals Ltd.
|
Bangladesh
|
Renewal
|
06 May 2024
|
02 April 2029
|
| View |
|
DR-XY43343
|
Minoxidil
|
Regain
|
20mg/mL (2%)
|
Topical Solution
|
Hair Regrowth Treatment (Other Dermatologicals)
|
Jewin Pharmaceutical (Shandong) Co. Ltd.
|
China
|
Renewal
|
01 May 2024
|
10 April 2029
|
| View |
|
DR-XY43344
|
Regorafenib
|
Stivarga
|
40 mg
|
Film-Coated Tablet
|
Antineoplastic
|
Bayer AG
|
Germany
|
Automatic Renewal (E-AR)
|
01 March 2024
|
08 April 2029
|
| View |
|
DR-XY43346
|
Ursodeoxycholic Acid
|
Ursogen
|
250 mg
|
Capsule
|
Bile Salt
|
Lloyd Laboratories, Inc.
|
Philippines
|
Renewal
|
16 January 2024
|
10 April 2029
|
| View |
|
DR-XY43347
|
Temozolomide
|
Temovex 250
|
250mg
|
Capsule
|
Antineoplastic
|
Admac Lifesciences
|
India
|
Renewal
|
11 September 2019
|
14 April 2029
|
| View |
|
DR-XY43355
|
Diethylcarbamazine Citrate
|
Unbranded
|
50mg
|
Tablet
|
Anthelmintic
|
Dupen Laboratories Pvt. Ltd.
|
India
|
Renewal
|
08 May 2024
|
15 April 2029
|
| View |
|
DR-XY43357
|
Palonosetron (as hydrochloride)
|
Aloxi
|
50 mcg/mL (75 mcg/1.5 mL)
|
Solution for I.V. Injection
|
Anti-emetic/Anti-nauseant [Serotonin (5HT3)
Antagonist]
|
Pierre Fabre Medicament Production
|
France
|
Automatic Renewal (E-AR)
|
23 February 2024
|
05 May 2029
|
| View |
|
DR-XY43358
|
AcicIovir
|
Optavir
|
30mg/g (3% w/w)
|
Ophthalmic Ointment
|
Antiviral
|
Remington Pharmaceutical (Pvt.) Ltd.
|
Pakistan
|
Renewal
|
29 March 2024
|
16 April 2029
|
| View |
|
DR-XY43367
|
Eperisone Hydrochloride
|
Myelax
|
50 mg
|
Tablet
|
Muscle Relaxant
|
Myungmoon Pharm., Co., Ltd.
|
Korea
|
Renewal
|
16 February 2024
|
28 April 2029
|
| View |
|
DR-XY43368
|
Orlistat
|
Orslim
|
120 mg
|
Hard Gelatin Capsule
|
Anti-Obesity
|
PharmEvo (Pvt.) Ltd.
|
Pakistan
|
Renewal
|
08 May 2024
|
28 April 2029
|